BridgeMD
New treatment option for Recurrent Breast Carcinoma
Official title Study on Recurrent Breast Cancer and Repeated Radiation Therapy
ClinicalTrials.gov ID: NCT06704659
What this study is testing
- What it's testing
- This study explores whether recurrent breast cancer can be safely treated with breast-conserving surgery and repeated radiation therapy in cases where patients have previously undergone radiation. Traditionally, recurrent breast cancer has been treated by removing the entire breast.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 55 and older, women only
You may be able to join if
- The patient has a diagnosed breast cancer or tumor area in the breast with a maximum diameter of 3 cm, where a previous breast-conserving surgery has...
- The patient has only a local recurrence, and imaging studies show no suspicion of metastases outside the breast (preoperative staging N0M0).
- At least 3 years have passed since the completion of prior radiation therapy. The new breast cancer can be technically treated with another...
- The patient is at least 55 years old at the time of surgery. The patient is willing to participate in the study. The patient is capable of providing...
You likely can't join if
- A booster dose, also known as a "boost," was administered during prior radiation therapy.
- Preoperative assessments suggest multifocal breast cancer, with the tumor area to be removed exceeding 3 cm.
- The planned radiation therapy per the study protocol cannot be administered due to factors such as shoulder joint stiffness, a pacemaker located in...
- The patient is unable to provide informed consent or is unwilling to participate in the study.
- Metastases outside the breast (e.g., axillary or distant metastases) are present.
The study team makes the final eligibility decision.
Where it's taking place
- Helsinki, Finland
- Turku, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 55 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Helsinki, Finland; Turku, Finland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.